Clinical Spectrum, independent risk factors, and treatment outcomes of pediatric arrhythmias: a multicenter retrospective analysis in Xinjiang - Takeaways - MDSpire

Clinical Spectrum, independent risk factors, and treatment outcomes of pediatric arrhythmias: a multicenter retrospective analysis in Xinjiang

  • By

  • Jinyong Pan

  • Yan Zhang

  • Yan Guo

  • Hu Li

  • Fengling Zhang

  • Muqing Niu

  • Heyun Xiong

  • Cailing Chen

  • Hongbin Yang

  • Hua Guan

  • Yong Sun

  • Zhou Zhang

  • Jing Lv

  • Yonglin Chen

  • May 29, 2026

  • 0 min

Share

  • 1

    The study analyzed 232 children with arrhythmias in Xinjiang, revealing a mean age of 11.5 years and a male predominance of 50.9%.

  • 2

    Supraventricular arrhythmias were the most prevalent, accounting for 49.1%, with paroxysmal supraventricular tachycardia (PSVT) at 35.3%.

  • 3

    Independent risk factors for pediatric arrhythmias included congenital heart disease, recent infection exposure, and recurrent arrhythmia history.

  • 4

    Management strategies included regular follow-up (65.5%), pharmacotherapy (25.0%), and radiofrequency catheter ablation (9.5%).

  • 5

    Ablation in PSVT patients achieved 100% acute success with no recurrence over 6-12 months, and the overall response rate was 88.2%.

Original Source(s)

Clinical Spectrum, independent risk factors, and treatment outcomes of pediatric arrhythmias: a multicenter retrospective analysis in Xinjiang

  • by Jinyong Pan, Yan Zhang, Yan Guo, Hu Li, Fengling Zhang, Muqing Niu, Heyun Xiong, Cailing Chen, Hongbin Yang, Hua Guan, Yong Sun, Zhou Zhang, Jing Lv, Yonglin Chen

  • May 29, 2026

Related Content

Tenecteplase Fails to Boost EVT Outcomes

Phase 3 stroke trial leaves open the possibility of clinically meaningful benefit or harm in selected late-window patients.

Top 10 States With Rising Demand for Physicians

These 10 states report physician shortages, projected physician supply gaps, or physician-to-population ratios below national benchmarks.

IPS Could Minimize GI Effects in Treating Iron Deficiency

Review summarizes pharmacokinetic and clinical data on iron protein succinylate across patients with iron deficiency and iron deficiency anemia.